ClinicalTrials.gg
Enrolling by invitationNCT06679478Updated Nov 13, 2024

Evaluation of Early Mobilization Protocol in Patients Undergoing Gastrointestinal Surgery

An interventional study of Enhanced Recovery After Surgery (ERAS) Early Mobilization Protocol in Gastrointestinal Diseases, sponsored by Uludag University. Enrolling by invitation at 1 site in Turkey. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-11-13.

Sponsored by Uludag University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Gastrointestinal Diseases with a site in Turkey — 3 open to participants now, 4 under way, none of them phase 3. Gastrointestinal Diseases · Turkey.

Started
2024
with 1 other
No phase
6 of 11
2 open now
Registered
8th of 11
by date

Among the 11 studies in Gastrointestinal Diseases with a site in Turkey, this one is one of 2 that started in 2024, is one of 6 with no phase, and was the 8th registered.

Gastrointestinal Diseases

549 studies on the registry are indexed under Gastrointestinal Diseases; 102 are open to participants now.

Browse Gastrointestinal Diseases studies →

Open to participants now

3 of the 11 studies in Gastrointestinal Diseases with a site in Turkey are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 66 Gastrointestinal Diseases studies recruiting now, 30 (45%) set no upper age limit and 23 (35%) stop at 75 or younger; 19 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Gastrointestinal Diseases with a site in Turkey, or all of them as a file.
02

Study summary

In this study, the investigators aimed to evaluate the early mobilization protocol created in accordance with the accelerated recovery guide after surgery in patients undergoing gastrointestinal surgery.

Read the detailed description

This study is an experimental study. The participants in the control group are applied to the mobilization applied in routine clinics. The participants in the intervention group are applied to the mobilization protocol created in accordance with the Enhanced Recovery After Surgery (ERAS) guidelines. It is planned to evaluate the postoperative mobilization process of both groups.

In this study, the researchers aimed to evaluate the early mobilization protocol created in accordance with the accelerated recovery guide after surgery in patients undergoing gastrointestinal surgery.

03

Conditions studied

  • Gastrointestinal Diseases

Keywords

  • Gastrointestinal Diseases
  • Enhanced Recovery After Surgery
  • Early Ambulation
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older
  • Agreeing to participate in the study
  • Being able to understand, speak Turkish or have no obstacle to communication
  • Having undergone open gastrointestinal surgery
  • Having an (ASA) score \<IV
  • Being fully independent according to the Modified Barthel Index during the pre-operative period
  • Staying in the hospital for at least 48 hours after the surgery
  • Having a phone
  • Agreeing to download the 'StepsApp Pedometer' application to their phone
  • Agreeing to carry the phone with them during the post-operative mobilization processes

Exclusion criteria

Exclusion Criteria:

  • Being taken into emergency surgery
  • Having had major gastrointestinal surgery before
  • Having a diagnosis that may restrict mobilization (neurological, cardiovascular, respiratory and musculoskeletal comorbidities)
  • High risk of falling in the preoperative period
  • Using medication that may affect mobilization
  • Having a diagnosis of any psychiatric disease
  • Having a Nutritional Risk Score score of ≥3
  • Being in contact isolation
  • Being morbidly obese
  • Being in intensive care for more than 24 hours during the postoperative period
  • Having an intubation period of more than 24 hours during the postoperative period
  • Developing a complication that may prevent mobilization after surgery
  • Withdrawing from participating in the study,
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • No intervention
    Mobilization Performed in Routine Clinic Group

    Participants undergoing gastrointestinal surgery will receive routine clinic mobilization. The investigator will not perform any interventions.

  • Experimental
    Early Mobilization Protocol Created in Enhanced Recovery After Surgery (ERAS) Guidelines Group

    Participants undergoing gastrointestinal surgery will watch a video 1 day before surgery that includes information about the importance of mobilization and the process. The participant will be applied a mobilization protocol created in line with the postoperative mobilization eras (enhanced recovery after surgery) guidelines.

    Procedure: Enhanced Recovery After Surgery (ERAS) Early Mobilization Protocol

Interventions

  • ProcedureEnhanced Recovery After Surgery (ERAS) Early Mobilization Protocol

    The intervention is applied from the first day after surgery until discharge. (including the day of discharge).

    Also known as: Early Mobilization Protocol

06

What researchers measure

Primary outcomes

  1. The effect of the ERAS (Enhanced Recovery After Surgery) early mobilization protocol on the number of steps taken daily after surgery

    The number of steps taken by the participant daily after surgery will be measured via a phone pedometer application (StepsApp).

    Time frame: From admission to discharge, up to 1 week

  2. The effect of the ERAS (Enhanced Recovery After Surgery) early mobilization protocol on the distance moved after surgery

    The daily distance moved by the participant after surgery will be measured via a phone pedometer application (StepsApp).

    Time frame: From admission to discharge, up to 1 week

  3. The effect of the ERAS early mobilization protocol on the recovery of the gastrointestinal system after surgery

    The researcher will record the day the participant first passed gas after surgery and the date of his/her first defecation.

    Time frame: From admission to discharge, up to 1 week

  4. The effect of the ERAS (Enhanced Recovery After Surgery) early mobilization protocol on the level of ability to perform daily living activities after surgery

    The researcher makes the measurement with the Modified Barthel Index scale. Modified Barthel Index: The highest score is 100, the lowest score is 0. The patient is stated as fully dependent in the range of 0-20 points, highly dependent in the range of 21-61 points, moderately dependent in the range of 62-90 points, slightly dependent in the range of 91-99 points, and fully independent in the range of 100 points. Daily evaluations are made until discharge after surgery.

    Time frame: (From admission to discharge, up to 1 week) and (When he comes for a check-up 1 week after discharge)

07

Study locations

1 site
  • Derya Şayır Köksal
    Kütahya, 43100, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Nov 2025, 11 months after the start.

Of 127 non-industry interventional studies with no phase under Gastrointestinal Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 11 months is below that.

Counting every sponsor, half of 149 studies reached it within 24 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2024
First posted
Nov 7, 2024
StartActual
Nov 11, 2024
Primary completionEst.
Nov 1, 2025
CompletionEst.
Nov 9, 2025
Last update
Nov 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06679478
Lead sponsor
Uludag University
Responsible party
Derya Şayır Koksal (lecturer, Uludag University) — Principal investigator
First posted
Nov 7, 2024
Start date
Nov 11, 2024
Primary completion
Nov 1, 2025 (estimated)
Completion
Nov 9, 2025 (estimated)
Last update
Nov 13, 2024

Study contacts

Derya Şayır Köksal, Lecturer
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion